Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • BSE

    Tag: bse

    You Searched For "BSE"
    Lupin receives FDA approval for Clobazam Oral Suspension

    Lupin receives FDA approval for Clobazam Oral Suspension

    Farhat Nasim1 Jan 2019 10:00 AM IST
    Lupin's Clobazam Oral Suspension, 2.5 mg/mL is the generic version of Lundbeck Pharmaceuticals, LLC's Onfi Oral Suspension, 2.5 mg/mL. It is indicated...
    Cadila Healthcare arm gets USFDA nod to market Ranitidine injection

    Cadila Healthcare arm gets USFDA nod to market Ranitidine injection

    Medical Dialogues Bureau12 Dec 2018 10:00 AM IST
    NEW DELHI: Drug firm Cadila Healthcare on Tuesday said its subsidiary has received approval from the US health regulator to market Ranitidine...
    Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

    Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

    Medical Dialogues Bureau10 Dec 2018 9:15 AM IST
    New Delhi: Drug firm Alembic Pharma on Monday said it has received approval from the US health regulator for Olopatadine Hydrochloride ophthalmic...
    HUL, GSK Consumer shares rise 4 pc after boards approve merger

    HUL, GSK Consumer shares rise 4 pc after boards approve merger

    Medical Dialogues Bureau5 Dec 2018 9:57 AM IST
    New Delhi: Shares of Hindustan Unilever and Glaxo Smith Kline (GSK) Consumer Healthcare Monday surged 4 per cent on BSE after their boards approved...
    Sun Pharma to acquire Japan

    Sun Pharma to acquire Japan's Pola Pharma for Rs 7 crores approx

    Medical Dialogues Bureau27 Nov 2018 4:20 PM IST
    New Delhi: Sun Pharma on Monday said it will acquire Japan-based Pola Pharma for around USD 1 million, (approximately Rs 7 crores) to strengthen its...
    Indoco Remedies gets two minor observations from USFDA for Goa plants

    Indoco Remedies gets two minor observations from USFDA for Goa plants

    Medical Dialogues Bureau25 Nov 2018 9:07 AM IST
    Mumbai: Drug firm Indoco Remedies on Thursday said it has received two minor observations from the US health regulator for its Goa-based two plants....
    Piramal Enterprises plans to raise up to Rs 1,000 crore via non-convertible debentures

    Piramal Enterprises plans to raise up to Rs 1,000 crore via non-convertible debentures

    Medical Dialogues Bureau22 Nov 2018 4:37 PM IST
    NEW DELHI: Piramal Enterprises on Wednesday said it plans to raise up to Rs 1,000 crore through issue of secured non-convertible debentures (NCDs) on...
    Lupin launches generic Tetrabenazine Tablets

    Lupin launches generic Tetrabenazine Tablets

    Medical Dialogues Bureau22 Nov 2018 4:26 PM IST
    Mumbai: Pharma major Lupin announced the launch of Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the United States Food...
    Ajanta Pharma launches generic ADHD treatment drug in US

    Ajanta Pharma launches generic ADHD treatment drug in US

    Ruby Khatun Khatun23 Nov 2017 10:15 AM IST
    New Delhi: Drug firm Ajanta Pharma said it has launched generic Clonidine Hydrochloride extended-release tablets in the American market after...
    Prev

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok